摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

thiacycloheptan-3-one 1,1-dioxide | 36165-01-2

中文名称
——
中文别名
——
英文名称
thiacycloheptan-3-one 1,1-dioxide
英文别名
thiepan-3-one-1,1-dioxide;1,1-dioxo-1λ6-thiepan-3-one;thiacycloheptane-3-one-1, 1-dioxide;thiacycloheptane-3-one-1,1-dioxide;1-Thiacycloheptan-3-on-1,1-dioxid;1,1-dioxothiepan-3-one
thiacycloheptan-3-one 1,1-dioxide化学式
CAS
36165-01-2
化学式
C6H10O3S
mdl
——
分子量
162.21
InChiKey
YZZMNMCXPNZNIU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    108-110 °C
  • 沸点:
    385.4±35.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    59.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Potassium channel openers
    申请人:Abbott Laboratories
    公开号:US06265417B1
    公开(公告)日:2001-07-24
    Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    具有该化学式的化合物在治疗由钾通道开放剂预防或改善的疾病方面是有用的。还公开了钾通道开放组合物和在哺乳动物中开放钾通道的方法。
  • [EN] POTASSIUM CHANNEL OPENERS<br/>[FR] COMPOSES OUVRANT LES CANAUX POTASSIUM
    申请人:ABBOTT LABORATORIES
    公开号:WO1999031059A1
    公开(公告)日:1999-06-24
    (EN) Compounds having the formula (I) are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.(FR) L'invention concerne des composés représentés par la formule (I), qui sont utiles pour le traitement des maladies qu'il est possible de prévenir ou d'améliorer au moyen de composés ouvrant les canaux potassium. L'invention concerne également des compositions permettant d'ouvrir les canaux potassium et un procédé permettant d'ouvrir les canaux potassium chez un mammifère.
    (EN) 具有公式(I)的化合物在治疗由钾通道开放剂预防或改善的疾病方面具有用途。还公开了开放钾通道的组合物和在哺乳动物中开放钾通道的方法。 (FR) 公式(I)表示的化合物对于治疗通过钾通道开放剂预防或改善的疾病具有用途。还揭示了开放钾通道的组合物和在哺乳动物中开放钾通道的方法。
  • Substituted thiacycloalkeno [3,2-b] pyridines, methods of preparation, compositions and method of use
    申请人:ORTHO PHARMACEUTICAL CORPORATION
    公开号:EP0241281A2
    公开(公告)日:1987-10-14
    Novel substituted thiacycloalkeno [3,2-b] pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and anti- bronchoconstrictor activity.
    介绍了新型取代的硫代环烯烃 [3,2-b] 吡啶。这些化合物是有用的钙通道拮抗剂,具有心血管、抗哮喘和抗支气管收缩活性。
  • Synthesis and Structure−Activity Relationships of a Novel Series of 2,3,5,6,7,9-Hexahydrothieno[3,2-<i>b</i>]quinolin-8(4<i>H</i>)-one 1,1-Dioxide K<sub>ATP</sub> Channel Openers:  Discovery of (−)-(9<i>S</i>)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-<i>b</i>]quinolin-8(4<i>H</i>)-one 1,1-Dioxide (A-278637), a Potent K<sub>ATP</sub> Opener That Selectively Inhibits Spontaneous Bladder Contractions
    作者:William A. Carroll、Robert J. Altenbach、Hao Bai、Jorge D. Brioni、Michael E. Brune、Steven A. Buckner、Christopher Cassidy、Yiyuan Chen、Michael J. Coghlan、Anthony V. Daza、Irene Drizin、Thomas A. Fey、Michael Fitzgerald、Murali Gopalakrishnan、Robert J. Gregg、Rodger F. Henry、Mark W. Holladay、Linda L. King、Michael E. Kort、Philip R. Kym、Ivan Milicic、Rui Tang、Sean C. Turner、Kristi L. Whiteaker、Lin Yi、Henry Zhang、James P. Sullivan
    DOI:10.1021/jm030356w
    日期:2004.6.1
    Structure-activity relationships were investigated on a novel series of sulfonyldihydropyridine-containing K-ATP openers. Ring sizes, absolute stereochemistry, and aromatic substitution were evaluated for K-ATP activity in guinea pig bladder cells using a fluorescence-based membrane potential assay and in a pig bladder strip assay. The inhibition of spontaneous bladder contractions in vitro was also examined for a select group of compounds. All compounds studied showed greater potency to inhibit spontaneous bladder contractions relative to their potencies to inhibit contractions elicited by electrical stimulation. In an anesthetized pig model of myogenic bladder overactivity, compound 14 and (-)-cromakalim 1 were found to inhibit spontaneous bladder contractions in vivo at plasma concentrations lower than those that affected hemodynamic parameters. Compound 14 showed approximately 5-fold greater selectivity than I in vivo and supports the concept that bladder-selective K-ATP channel openers may have utility in the treatment of overactive bladder.
  • A Convenient Multigram Scale Synthesis of Tetrahydrothiophene‐3‐one‐1,1‐dioxide
    作者:Robert J. Altenbach、Ladislav Kalvoda、William A. Carroll
    DOI:10.1081/scc-120027703
    日期:2004.12.31
    A short and efficient multigram scale synthesis of tetrahydrothiophene-3-one-1,1-dioxide is described.
查看更多

同类化合物

硫杂环庚烷-2-酮 硫杂环庚烷 环己硫醚 桉叶硫醚 四氢-6-硫代-1,4-乙桥-1H,3H-噻吩并(3,4-c)噻吩-3-酮 二氢-7-丁基-1,4-乙桥-1H,3H-噻吩并(3,4-c)噻吩-3,6(4H)-二酮 二氢-1,4-二甲基-1,4-乙桥-1H,3H-噻吩并(3,4-c)噻吩-3,6(4H)-二酮 二氢-1,4-乙基桥-1H,3H-噻吩并(3,4-c)噻吩-3,6(4H)-二酮 β.-D-半乳吡喃糖,1,6-二脱氧-1,6-环硫- 6-硫杂双环[3.2.1]辛烷 6-甲基-7-硫杂二环[4.1.0]庚烷 5-氧代噻吩-3-羧酸甲酯 5-氧代-4-噻吩甲酸乙酯 4,7,7-三甲基-6-硫代二环[3.2.1]辛烷 3-硫杂二环[3.2.1]辛烷-2-酮,1,8,8-三甲基-,(1R)- 3-甲基噻吩1,1-二氧化物 2-羟基噻烷 1-癸基2-[[1-(2-氯-5-磺基苯基)-4,5-二氢-3-甲基-5-羰基-1H-吡唑-4-基]偶氮]苯酸酯 1,6:4,5-二去氢-2,3-二脱氧-1-硫代己糖醇 (1S,4S,5S)-4,7,7-三甲基-6-硫代二环[3.2.4]辛烷 4-Acetoxy-5-chloro-3,3,6,6-tetramethylthiacycloheptane 3-phenylthiepan-3-ol 4-isopropenyl-1-methyl-7-thiabicyclo[4.1.0]heptane 8,9,10,11-tetrachloro-4-thiatricyclo<5.4.0.02,6>undeca-8,10-diene 4,4-dioxide cis-bicyclo<3.2.01,5>-3-thiepane-2,4-dione 1-phenyl-2,2,3,3-tetracyano-7,8-dithiabicyclo<3.2.1>octane 2-Thiabicyclo[3.2.2]non-5-en-3-one oxime 2-Thiabicyclo[3.2.2]nonan-3-one oxime 1,6-dideoxy-1,6-epithio-β-D-glucopyranose S,S-dioxide (3aS,4R,8S,8aR)-2,2-dimethylhexahydrothiepino[4,5-d][1,3]dioxole-4,8-diol (3aS,4R,8R,8aS)-2,2-Dimethyl-hexahydro-thiepino[4,5-d][1,3]dioxole-4,8-diol 2,2-dimethylhexahydrothiepino[4,5-d][1,3]dioxole-4,8-diol (1S,4R,5S)-4,7,7-Trimethyl-6-thia-1,5-bicyclo<3.2.1>octan-3-one 3,7-dithia(3.3.2)propellane-3,3,7,7-tetroxide 1-Methyl-4-(2-methylthiiran-2-yl)-7-thiabicyclo[4.1.0]heptane 3-Vinylcyclohexen-diepisulfid 7-tert-Butyl-4-methyl-8-oxa-3-thia-7-azabicyclo<4.2.1>nonan 9-Thiabicyclo[4.2.1]non-7-ene 9-Thiabicyclo[4.2.1]nonane 4-Thiahomoadamantane 4,4-Dioxide 4-Thiahomoadamantane 4-Thiahomoadamantan-2-one ethyl thiacyclohepten-4-one-3-carboxylate 1,1-dioxide 1-Morpholino-6-thia-bicyclo<3.2.0>heptan-S-dioxid 1,6-Bis-dec-9-enyl-9-thia-bicyclo[4.2.1]nonane 9,9-dioxide 4-methylthiepane 1,1-dioxide (S)-(1,1-dioxothiepan-4-yl)methanol (1,1-dioxothiepan-4-yl)methanol 3-thia-bicyclo[3.2.1]octane 1,6-Anhydo-1(6)-thio-L-idit